| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 105.717 | 72 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 90.5287 | 69 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 100.799 | 71 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 83.928 | 66 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 94.5041 | 69 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 113.549 | 73 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 93.2623 | 69 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 74.9766 | 63 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 76.8981 | 64 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 98.2352 | 69 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 98.9615 | 70 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 110.743 | 72 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 83.8365 | 64 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 77.1951 | 62 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 94.4035 | 69 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 89.4933 | 67 |